Navigation Links
Retroviral resistance gene found

Dr. Stephen Goff and colleagues have identified a novel retroviral resistance gene, called FEZ1, that can mediate a potent resistance to murine leukemia virus, as well as HIV-1, in cell culture. The researchers found that the high level of FEZ1 expression in a specific laboratory rat cell line caused a significant block to retroviral infection ?retroviruses were able to enter the host cells and synthesize the viral DNA, but were excluded from entering the host cell nucleus.

"We suspect that the overexpression of FEZ1 interferes with intracellular trafficking of the viral preintegration complex and traps the viral DNA in the cytoplasm. We hope that learning more about this transport machinery might reveal a new target for antiviral drugs in the treatment of HIV-1 disease."


'"/>

Source:Cold Spring Harbor Laboratory


Page: 1

Related biology news :

1. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
2. Researchers make gains in understanding antibiotic resistance
3. MUHC scientists describe genetic resistance to rampant virus
4. New polysaccharide may help combat multidrug resistance in cancer
5. New book explains antibiotic resistance for a broad audience
6. Insects develop resistance to engineered crops
7. Drug resistance testing in treatment-naive HIV patients is cost-effective
8. Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance
9. Gaining ground in the race against antibiotic resistance
10. Genes linked to treatment resistance in children with leukemia
11. Einstein researchers identify new way that bacteria develop resistance to antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Retroviral resistance gene found

(Date:4/15/2014)... Academy of Arts and Sciences (KNAW) has announced the ... awarded prestigious Heineken Prizes (one million US dollars prize ... for their great merits to science. , This year ... awarded to the Austrian-American chemist Erwin Chargaff in 1964. ... Prizes to the following laureates: , Christopher ...
(Date:4/15/2014)... 2050, deforestation could cause temperatures in the Congo ... would intensify warming caused by greenhouse gases by ... the University of Leuven, Belgium. , Explosive population ... destruction of tropical rainforests in Central Africa. A ... examined how these practices will affect longer-term temperatures ...
(Date:4/15/2014)... of Adelaide research into parasites of cuttlefish, squid ... astonishing life cycles, and shown how they may ... Researcher Dr Sarah Catalano has described 10 new ... the kidneys of cephalopods (cuttlefish, squid and octopus). ... to be described from Australian waters. , ...
Breaking Biology News(10 mins):Five scientists awarded prestigious Heineken Prizes 2Study: Deforestation could intensify climate change in Congo Basin by half 2Bizarre parasite may provide cuttlefish clues 2
... Human Genome Research Institute (NHGRI), one of the National ... of sequencing targets, with an emphasis on enhancing the ... differences between individuals influence the risk of health and ... Research, which is a federally chartered committee that advises ...
... Comprehensive Cancer Center say that just one, single, malfunctioning ... discovery offers new insight into the development of some ... time underscores the powerful role that these tiny snippets ... in carcinogenesis. , "To the best of our ...
... Coast fever destroys the small farmer's dream of escaping poverty ... some $200 million annually, this tick-borne disease rages across a ... team of scientists has taken the first major step toward ... in the February 13-17 early online edition of the ...
Cached Biology News:NHGRI announces new sequencing targets 2NHGRI announces new sequencing targets 3NHGRI announces new sequencing targets 4Single microRNA causes cancer in transgenic mouse 2Single microRNA causes cancer in transgenic mouse 3Genomics-based vaccine could prevent deadly cattle disease 2Genomics-based vaccine could prevent deadly cattle disease 3
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 ... based on the products of cells grown under ... entered into an international license agreement with Suneva ... proprietary multipotent cell conditioned media (CCM). ... existing license between Histogen and Suneva Medical, through ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research ... ALQA). Alliqua is an emerging biomedical company acquiring, ... the wound care market. , Free report download: ... was restructured with a seasoned management team and ... become a leading provider of wound care products. ...
(Date:1/14/2014)... 14, 2014 iLab Solutions, the leader ... as the new Director of Product Strategy. In this ... as well as iLab sub-teams to guide in the ... to ensure that iLab provides the maximum possible benefit ... user-friendly, and high-impact solution in the world. , ...
(Date:1/14/2014)... Rockville, MD (PRWEB) January 14, 2014 ... dedicated to developing innovative information technology solutions for ... other health care stakeholders, announced today the signing ... the US Food and Drug Administration (FDA). ... to challenges related to patient safety, clinical outcomes, ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Revenue Grows 15 Percent Quarter-over-Quarter -, PALO ALTO, Calif., ... reported financial results for the second quarter,ended June 30, 2008., ... reported a net loss of,$4.3 million, or $0.07 per share. ... per share, for the prior quarter ended March 31, 2008 ...
... 31 Idenix,Pharmaceuticals, Inc. (Nasdaq: IDIX ) ... overview at the Bank of America 2008 Specialty,Pharmaceuticals ... ET at the,Southampton Inn, Long Island, NY., ... presentation can be,accessed under "Calendar of Events" in ...
... 31 Vista Partners announced today,that it has ... which target billion dollar markets, are progressing through,the ... present Phase 2 results for,Convivia(TM) sometime in the ... approval,of Delayed Release (DR) Cysteamine for the treatment ...
Cached Biology Technology:CV Therapeutics Reports 2008 Second Quarter Financial Results 2CV Therapeutics Reports 2008 Second Quarter Financial Results 3CV Therapeutics Reports 2008 Second Quarter Financial Results 4CV Therapeutics Reports 2008 Second Quarter Financial Results 5CV Therapeutics Reports 2008 Second Quarter Financial Results 6CV Therapeutics Reports 2008 Second Quarter Financial Results 7Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP) 2